Quantum-Si (NASDAQ:QSI) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.17) by 35.29 percent. This is a 76.92 percent decrease over losses of $(0.13) per share from the same period last year.
Cadrenal Therapeutics Provides Q2 2023 Corporate Update; As Of August 14, 2023, Cash Balances Were $9.6M
Recent Highlights
Expanded focus for tecarfarin development for patients with implanted medical devices such as left ventricular assist devices (LVADs) for heart diseases, an addressable market opportunity of
